With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

We want to hear your thoughts on what mRNA could do for cell and gene therapy